Information  X 
Enter a valid email address

Rio Tinto (RIO)

  Print      Mail a friend       Annual reports

Friday 14 September, 2018

Rio Tinto

Hydro terminates offer for aluminium assets

RNS Number : 8507A
Rio Tinto PLC
14 September 2018
 

Hydro terminates offer for Rio Tinto aluminium assets

 

14 September 2018

 

Rio Tinto has been informed by Hydro that it has withdrawn its offer to acquire the ISAL smelter in Iceland, its 53.3 per cent share in the Aluchemie anode plant in the Netherlands and its 50 per cent share in the Aluminium fluoride plant in Sweden, announced on 26 February 2018.

 

Following initial feedback from the European Commission (EC), Hydro has withdrawn its EC merger filing and terminated the transaction.

 

Contacts

 

[email protected] 

 

riotinto.com  

 

Follow @RioTinto on Twitter

 

Media Relations, United Kingdom

Illtud Harri

T +44 20 7781 1152

M +44 7920 503 600

 

David Outhwaite

T +44 20 7781 1623

M +44 7787 597 493

 

Media Relations, Australia

Jonathan Rose

T +61 3 9283 3088

M +61 447 028 913

 

Media Relations, Canada

Matthew Klar

T +1 514 608 4429
 

 

Investor Relations, United Kingdom

John Smelt

T +44 20 7781 1654

M +44 7879 642 675

 

David Ovington

T +44 20 7781 2051

M +44 7920 010 978

 

Nick Parkinson

T +44 20 7781 1552

M +44 7810 657 556

 

Investor Relations, Australia

Natalie Worley

T +61 3 9283 3063

M +61 409 210 462

 

Rachel Storrs

T +61 3 9283 3628

M +61 417 401 018

 

 

Rio Tinto plc

6 St James's Square

London SW1Y 4AD

United Kingdom

 

T +44 20 7781 2000
Registered in England

No. 719885

Rio Tinto Limited

Level 7, 360 Collins Street

Melbourne 3000

Australia

 

T +61 3 9283 3333

Registered in Australia

ABN 96 004 458 404

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
MSCFKQDBDBKDNCD

a d v e r t i s e m e n t